COEP
Price
$7.54
Change
+$0.06 (+0.80%)
Updated
Jul 3 closing price
Capitalization
26.49M
NRXP
Price
$3.38
Change
-$0.00 (-0.00%)
Updated
Jul 7, 11:22 AM (EDT)
Capitalization
65.92M
Interact to see
Advertisement

COEP vs NRXP

Header iconCOEP vs NRXP Comparison
Open Charts COEP vs NRXPBanner chart's image
Coeptis Therapeutics Holdings
Price$7.54
Change+$0.06 (+0.80%)
Volume$20.94K
Capitalization26.49M
NRX Pharmaceuticals
Price$3.38
Change-$0.00 (-0.00%)
Volume$100
Capitalization65.92M
COEP vs NRXP Comparison Chart in %
Loading...
COEP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COEP vs. NRXP commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COEP is a Hold and NRXP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (COEP: $7.54 vs. NRXP: $3.38)
Brand notoriety: COEP and NRXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COEP: 49% vs. NRXP: 30%
Market capitalization -- COEP: $26.49M vs. NRXP: $65.92M
COEP [@Biotechnology] is valued at $26.49M. NRXP’s [@Biotechnology] market capitalization is $65.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COEP’s FA Score shows that 0 FA rating(s) are green whileNRXP’s FA Score has 0 green FA rating(s).

  • COEP’s FA Score: 0 green, 5 red.
  • NRXP’s FA Score: 0 green, 5 red.
According to our system of comparison, NRXP is a better buy in the long-term than COEP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COEP’s TA Score shows that 4 TA indicator(s) are bullish while NRXP’s TA Score has 3 bullish TA indicator(s).

  • COEP’s TA Score: 4 bullish, 6 bearish.
  • NRXP’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both COEP and NRXP are a bad buy in the short-term.

Price Growth

COEP (@Biotechnology) experienced а -6.10% price change this week, while NRXP (@Biotechnology) price change was -3.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRXP($65.9M) has a higher market cap than COEP($26.5M). NRXP YTD gains are higher at: 53.636 vs. COEP (37.091). COEP has higher annual earnings (EBITDA): -9.95M vs. NRXP (-24.11M). NRXP has more cash in the bank: 5.55M vs. COEP (4.27M). COEP has less debt than NRXP: COEP (2.04M) vs NRXP (8.4M). COEP has higher revenues than NRXP: COEP (62.9K) vs NRXP (0).
COEPNRXPCOEP / NRXP
Capitalization26.5M65.9M40%
EBITDA-9.95M-24.11M41%
Gain YTD37.09153.63669%
P/E RatioN/A0.36-
Revenue62.9K0-
Total Cash4.27M5.55M77%
Total Debt2.04M8.4M24%
FUNDAMENTALS RATINGS
COEP vs NRXP: Fundamental Ratings
COEP
NRXP
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
6237
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NRXP's Valuation (57) in the null industry is in the same range as COEP (72). This means that NRXP’s stock grew similarly to COEP’s over the last 12 months.

COEP's Profit vs Risk Rating (95) in the null industry is in the same range as NRXP (100). This means that COEP’s stock grew similarly to NRXP’s over the last 12 months.

COEP's SMR Rating (99) in the null industry is in the same range as NRXP (100). This means that COEP’s stock grew similarly to NRXP’s over the last 12 months.

NRXP's Price Growth Rating (37) in the null industry is in the same range as COEP (62). This means that NRXP’s stock grew similarly to COEP’s over the last 12 months.

NRXP's P/E Growth Rating (94) in the null industry is in the same range as COEP (100). This means that NRXP’s stock grew similarly to COEP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COEPNRXP
RSI
ODDS (%)
Bullish Trend 5 days ago
80%
Bearish Trend 5 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
65%
Bearish Trend 5 days ago
74%
Momentum
ODDS (%)
Bearish Trend 6 days ago
55%
Bullish Trend 5 days ago
71%
MACD
ODDS (%)
Bearish Trend 6 days ago
57%
Bearish Trend 5 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
69%
Bearish Trend 5 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
74%
Bullish Trend 5 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
62%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
77%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
75%
Bearish Trend 5 days ago
83%
Aroon
ODDS (%)
Bearish Trend 5 days ago
80%
Bullish Trend 5 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
COEP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVMLF0.460.01
+2.78%
Sovereign Metals Ltd.
KARX0.98N/A
N/A
Karbon-X Corp.
BCCMY2.47N/A
N/A
BAIC MTR CORP LTD
SMTOF20.70N/A
N/A
Sumitomo Electric Industries Ltd.
SUME1.00N/A
N/A
Summer Energy Holdings, Inc.

COEP and

Correlation & Price change

A.I.dvisor indicates that over the last year, COEP has been loosely correlated with TVRD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if COEP jumps, then TVRD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COEP
1D Price
Change %
COEP100%
+0.80%
TVRD - COEP
38%
Loosely correlated
+1.40%
QRON - COEP
36%
Loosely correlated
N/A
NRXP - COEP
27%
Poorly correlated
+1.81%
APLT - COEP
26%
Poorly correlated
-5.41%
PDSB - COEP
25%
Poorly correlated
+4.72%
More

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with CDTX. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
+1.81%
CDTX - NRXP
85%
Closely correlated
+1.90%
NBY - NRXP
84%
Closely correlated
+0.62%
NCNA - NRXP
84%
Closely correlated
-5.13%
RNAC - NRXP
83%
Closely correlated
-1.41%
ALLR - NRXP
83%
Closely correlated
+1.00%
More